MYGN
Myriad Genetics, Inc. · Healthcare
Director Paul Bisaro bought $28K of Myriad Genetics, Inc.
Bought$27,638
$3.69Price
7,500Shares
+8%Stake
What MYGN did for a copier
- $1,000 copied at Fri, May 15 open, $3.62
- $1,577
- S&P 500, same days
- +0.7%
Measured over 30 trading days, to the Jun 30 close.
Paul Bisaro's record
4 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 14. Filed Thu, May 14, 5:16 PM ET, after the close. Returns use the May 15 open and the Jun 30 close. Not investment advice.